Related by context. All words. (Click for frequent words.) 71 Ebola Marburg 69 viral hemorrhagic fevers 67 hemorrhagic fever viruses 65 nanoviricides 65 biodefense pathogens 64 NEUGENE 64 Neutralizing antibodies 63 viral hemorrhagic fever 63 polymerase inhibitors 62 influenza subtypes 62 herpes simplex viruses 61 Rabies Dengue fever 61 avian H#N# 61 viral subtypes 61 hemorrhagic fever virus 60 viral pathogens 60 cryptococcosis 60 Ebola viruses 60 Dengue viruses 60 nanoviricides ® 60 therapeutic monoclonal antibodies 60 Neugene 60 prophylactic vaccines 60 fungal bacterial 60 recombinant antibodies 60 gastro intestinal inflammation 60 NovaBay Aganocide compounds 59 HIV integrase inhibitors 59 oncolytic 59 hemorrhagic fevers 59 NEUGENE antisense 59 NS5b 59 radezolid 59 Thiovir 59 prophylactic vaccine 59 filoviruses 59 Francisella tularensis 59 TCAD therapy 59 Pneumocystis pneumonia PCP 59 thiazolides 59 pox viruses 59 anthrax plague 58 dengue viruses 58 CYT# potent vascular disrupting 58 signal transduction inhibitors 58 TLR9 agonist 58 P#X# antagonist 58 mAbs 58 siRNA compounds 58 proteasome inhibitor 58 Cytomegalovirus CMV 58 humanized monoclonal antibodies 58 Hendra viruses 58 siRNA sequences 58 arenaviruses 58 Viprovex TM 57 AEG# 57 Plasmodium vivax 57 anthrax tularemia 57 Monoclonal antibodies 57 reverse transcriptase inhibitors 57 immunomodulatory 57 agonists antagonists 57 JAK inhibitors 57 reemerging infectious diseases 57 particles VLPs 57 NEUGENE R 57 cytomegalovirus CMV HAE 57 bacterium Mycobacterium tuberculosis 57 siRNA therapeutics 57 Anidulafungin 57 Tarvacin Anti Viral 57 recombinant subunit vaccine 57 azoles 57 AdVac ® 57 kidney urologic 57 flaviviruses 57 Chemokine Receptor 57 pneumocystis pneumonia PCP 57 PORxin TM platforms 57 attenuated strain 57 antiviral therapies 57 Phylomer ® 56 Protease inhibitors 56 immunotoxins 56 Alferon LDO 56 neuraminidase inhibitor 56 filoviruses Ebola 56 Metarhizium anisopliae 56 Simian Immunodeficiency Virus 56 human African trypanosomiasis 56 Enterococcus faecium 56 Babesia 56 HCV polymerase 56 Burkholderia pseudomallei 56 HTS assay 56 meropenem 56 carbapenem 56 novel antibody therapeutics 56 antiviral compounds 56 cyclophilin inhibitors 56 Tarvacin TM 56 Ebola hemorrhagic fever 56 anticancer therapeutics 56 serogroup B 56 address untreatable bioterror 56 BAL# [001] 56 Ebola haemorrhagic fever 56 particle VLP 56 arboviruses 56 acne impetigo 56 DermaVir 56 antifungal agents 56 hepatitis C lupus 56 multidrug resistant strains 56 humanized antibodies 56 Streptococcus pneumonia 56 immune stimulatory 56 Multiple Sclerosis Rheumatoid Arthritis 56 pDNA vaccines 56 anti PlGF 56 novel VDA molecule 56 antimicrobial compounds 56 African trypanosomiasis 56 dependent cellular cytotoxicity 56 Ebola virus 56 inhibit replication 56 Janus kinase 56 vaccine adjuvants 56 Lassa virus 56 resistant pathogens 55 plasmodium parasite 55 orally administered inhibitor 55 immune modulators 55 Nanobodies 55 JAK3 55 immunomodulator 55 MVA BN R 55 Viprovex R 55 CD# CEA 55 anticancer antiviral 55 oncolytic viruses 55 antisense compounds 55 echinocandins 55 Epothilones 55 selectively inhibit replication 55 selective orally bioavailable 55 replicon 55 resistant microorganisms 55 small molecule defensin 55 Drug resistant strains 55 immunobiotics 55 anti infective treatments 55 pathophysiological effects 55 transmissible spongiform encephalopathies TSEs 55 immunotherapeutic approaches 55 JAK2 inhibitor 55 monoclonal antibodies 55 RNAi therapeutic targeting 55 small molecule inhibitors 55 Adenovirus 55 varicella zoster virus VZV 55 Plasmodium species 55 oral antiviral 55 NS4A 55 LNP formulations 55 influenza VLP vaccine 55 EV# vaccine 55 INxin TM 55 arthropod borne 55 Culex quinquefasciatus 55 Nanobodies ® 55 Vaccine Candidate 55 Interferons 55 AMPK activators 55 CCR5 antagonist 55 Psittacosis 55 outer membrane proteins 55 Bacillus anthracis anthrax 55 nanoviricide drug 55 Candida species 55 Paratuberculosis para TB 55 candidates Azedra TM 55 bacterial parasitic 55 highly pathogenic strains 55 DAS# [001] 55 trypanosomiasis 55 non nucleoside HCV 55 haemorrhagic fevers 55 recombinants 55 rxRNA 55 antitumoral 55 tkRNAi 55 Sphingomab 55 Fc fusion protein 55 H5 N1 55 investigational protease inhibitor 55 IAP inhibitors 55 Delafloxacin 55 Antibiotic resistant 55 anticoagulant reversing agent 55 Dengue hemorrhagic fever DHF 55 Monoclonal Antibodies 55 Lenocta 55 Atripla combines 55 protein kinase inhibitor 55 SMaRT ™ 55 ImQuest 55 attach auristatin 55 Hepatitis C HCV 55 serine proteases 55 Monoclonal Antibody 55 variola 55 Entry Inhibitor 54 humanized monoclonal 54 Vidofludimus 54 Epstein Barr virus EBV 54 LymphoStat B belimumab 54 immunotherapeutics 54 Adenoviruses 54 Trypanosoma 54 non nucleoside inhibitor 54 immunogens 54 Novavax trivalent seasonal influenza 54 NS#/#A protease 54 itraconazole Sporanox 54 A3 adenosine receptor 54 oral prodrug 54 macrolide resistant 54 Nosema apis 54 RhuDex ® 54 vaccine adjuvant 54 reverse vaccinology 54 Vaxfectin 54 prokinetic agent 54 biodefense countermeasure 54 Escherichia coli O# 54 anionic backbone 54 YONDELIS R 54 Vancomycin resistant 54 rheumatoid arthritis psoriasis Crohn 54 bioinformatic approaches 54 monoclonal antibody mAb 54 mda 7 54 biologic therapeutics 54 ALN PCS 54 drug conjugates ADCs 54 nonbacterial 54 simplex virus 54 HCV polymerase inhibitors 54 NITD 54 immunotoxin 54 RiVax 54 Ebola virus infection 54 FGFR 54 potently inhibit 54 CDDO Im 54 gambiae 54 Immunotherapeutic 54 vancomycin resistant Staphylococcus aureus 54 Locked Nucleic Acid LNA 54 adenoviral vectors 54 hepatitis C HCV 54 Nanobody ® 54 plague bacterium Yersinia 54 SinuNase ™ 54 potent inhibitors 54 Ramoplanin 54 rifamycins 54 monoclonal antibodies MAbs 54 virosome 54 drug ISA# 54 Solazed TM 54 essential thrombocythemia ET 54 novel antiviral therapeutics 54 HIV AIDS malaria tuberculosis 54 delafloxacin 54 smallpox polio 54 Maribavir 54 Visceral leishmaniasis 54 splice variants 54 anti botulism antibody 54 imatinib Gleevec ® 54 HCV Hepatitis C 54 multiple sclerosis psoriasis 54 CHIKV 54 ZFP Therapeutics 54 NS5B polymerase 54 ALN TTR 54 tetravalent vaccine 54 H#N# Avian Influenza 54 novel RNAi therapeutics 54 Kosan dependence 54 paramyxoviruses 54 siRNA therapeutic 54 Virus HIV 54 JAK1 54 microtubule inhibitor 54 S. aureus strains 54 HCV protease inhibitors 54 Neglected Tropical Diseases NTDs 54 RNA therapeutics 54 cynomolgus macaques 54 MAbs targeting 54 human metapneumovirus 54 recombinant polyclonal antibodies 54 Nontuberculous Mycobacteria NTM 54 antisense oligonucleotides 54 HIV integrase inhibitor 54 platform HDL Mimetic 54 cytomegalovirus CMV 54 TLR9 agonists 54 anticancer therapies 54 polymerase inhibitor 54 SynCon 54 rxRNA compounds 54 Valortim TM 54 monoclonal antibody MAb 54 neutralizing antibody 54 Alfacell proprietary ribonuclease 54 Plasmodium parasite 54 RNA antagonists 54 cMET 54 virotherapy 54 VRX# [001] 54 MVA BN ® 54 Allergy Cardiovascular 54 tropical parasitic 54 preclinically 53 Modified Vaccinia Ankara MVA 53 chlamydial infections 53 Shigamabs ® 53 histone deacetylase HDAC 53 avian influenza viruses 53 proteasome inhibitors 53 Plasmodium ovale 53 inhibitor PRO 53 HCD# [002] 53 small molecule thrombopoietin 53 erlotinib Tarceva ® 53 Valortim ® 53 Respiratory Syncytial Virus RSV 53 drugable targets 53 Zaire subtype 53 Dengue Virus 53 synthetic peptides 53 Transfection Reagent 53 beta defensins 53 bioterror agents 53 CCR5 mAb 53 antibiotic resistant bacterial infections 53 Protexia ® 53 transfection reagents 53 filovirus 53 candidate custirsen 53 herpesviruses 53 Interferon alpha 53 Vector Borne 53 antisense drugs 53 2 inhibitor CYT# 53 therapeutic monoclonal antibody 53 Vaccine Adjuvant 53 MKC# MT 53 plague tularemia 53 Invasive fungal infections 53 NuMimetic TM 53 Pandemic Influenza Vaccine 53 C5aR 53 biowarfare agents 53 HER pathway 53 targeted radiotherapeutic 53 immune modulator 53 Maxy G# 53 S.aureus 53 daptomycin 53 Tarvacin 53 immunomodulators 53 peptide antigens 53 adenoviral 53 F. tularensis 53 Radilex 53 serotypes strains 53 pneumococcus bacteria 53 receptor specificity 53 HBV vaccine 53 immunotherapeutic vaccine 53 oral proteasome inhibitor 53 DiLA2 53 SynCon ™ DNA 53 telomerase inhibitor 53 H. influenzae 53 flavopiridol 53 DNA plasmids 53 Plasmodium falciparum 53 papillomaviruses 53 Cathepsin S 53 Entamoeba histolytica 53 Elvitegravir 53 enzyme reverse transcriptase 53 LymphoStat B TM 53 virus HCV protease inhibitor 53 predictive biomarkers 53 poxvirus 53 Pertuzumab 53 Salmonella typhi 53 HCV NS3 protease 53 HuLuc# 53 Granulocyte Colony Stimulating Factor 53 gastrointestinal disorders ATI 53 virulence genes 53 CD# monoclonal antibody 53 NPC 1C 53 Adjuvanted 53 Ebola 53 tuberculosis hepatitis B 53 HQK 53 trastuzumab Herceptin R 53 rxRNA TM compounds 53 Pharmos pipeline 53 anti CD# monoclonal 53 PEGylated 53 virosomes 53 Oragens R 53 DispersinB ® 53 anti CD# antibodies 53 IAP inhibitor 53 Deforolimus 53 investigational compounds 53 mucosal vaccines 53 prodrugs 53 oral JAK1 53 malaria parasite Plasmodium falciparum 53 Homspera TM 53 topical microbicides 53 anti miRs antisense oligonucleotide 53 Brucella abortus 53 arenavirus 53 multi kinase inhibitor 53 TRAIL receptor antibodies 53 flavivirus 53 OncoVex 53 Aganocide 53 USA# strain 53 Curaxins 53 Provectus Pharmaceuticals specializes 53 cytotoxic T lymphocyte 53 RECOTHROM R 53 bacterial respiratory infections 53 Chlamydia trachomatis 53 Ribavirin causes 53 engineered RAP peptides 53 investigational humanized monoclonal antibody 53 Protexia R 53 HPV Human Papilloma 53 MEK inhibitors 53 cardio renal 53 novel peptides 53 potent cytotoxic 53 rheumatoid arthritis multiple sclerosis 53 immune modulating 53 smallpox anthrax 53 Cethromycin 53 novel immunomodulatory 53 organ transplant rejection 53 CTLA4 Ig 53 TTR amyloidosis 53 JAK2 enzyme 53 neuraminidase inhibitors 53 antisense therapies 53 AVP #D# 53 chronic HCV infection 53 MDR Gram negative 53 CCR5 inhibitors 53 Factor Receptor 53 nucleotide analogs 53 Poliovirus 53 Integrase inhibitors 53 protozoan parasites 53 phage display 53 cytotoxin 53 RNAi therapeutic 53 Pfizer Selzentry 53 viral haemorrhagic fevers 53 cytoprotective 53 staphylococcal vaccine 53 antisense inhibitors 52 bacterial fungal 52 Evoltra ® 52 Aganocide ® 52 vancomycin resistant 52 Enterobacter cloacae 52 tubulin inhibitor 52 NITD# 52 psoriasis rheumatoid arthritis 52 PNP inhibitor 52 dAbs 52 subunit vaccine 52 pharmacogenomic translational research 52 interferon lambda 52 TLR antagonists 52 neuropsychiatric diseases 52 Onconase 52 blood coagulation disorders 52 SIRT1 activators 52 nucleotide analogue 52 TLR agonists 52 recombinant vaccines 52 proprietary PEGylation 52 EZN 52 MT#/MEDI-# 52 Viral Immunotherapy platform 52 immunomodulatory properties 52 nucleoside analogs 52 Epidermal Growth Factor Receptor 52 TRIOLEX HE# APOPTONE HE# 52 Rigel R# 52 Teplizumab 52 monoclonal antibody therapeutics 52 selective immunoproteasome inhibitor 52 HPV vaccine protects 52 IMPDH 52 antisense drug 52 inflammatory autoimmune diseases 52 aminoglycosides 52 novel peptide 52 adenosine A2A 52 antiviral therapeutics 52 myelofibrosis polycythemia vera 52 CEQ# 52 Panzem 52 polyclonal 52 beta lactams 52 agonistic human 52 vinca alkaloid 52 GlycoPEGylated hemostasis compounds 52 macrolides 52 Human Immuno deficiency 52 virology immunology 52 AVI NEUGENE 52 multidrug resistant MDR 52 generation NEUGENE antisense 52 mGluR2 NAM 52 cSSSIs 52 viral respiratory infections 52 polioviruses 52 AAG geldanamycin analog 52 Enterobacteriaceae 52 infectious diseases autoimmune diseases 52 HCV NS5B polymerase 52 novel therapeutic antibodies 52 anthrax botulism typhoid 52 diagnostic biomarkers 52 oral Janus kinase 52 NXL# 52 Acquired Immunodeficiency Syndrome 52 VivaGel ™ 52 virus AAV 52 beta lactam 52 Mosquitoes transmit 52 ArQule Kinase Inhibitor Platform 52 P. reichenowi 52 Talabostat 52 rheumatoid arthritis thrombocytopenia 52 proteins peptides 52 targeting CD# 52 herpes virus infections 52 anti CD3 52 vancomycin resistant Enterococcus 52 Highly Pathogenic 52 immunized monkeys 52 diagnostic molecular imaging 52 drug resistant Acinetobacter 52 anti secretory 52 Monoclonal antibody 52 antibiotic resistant strains 52 immunosuppressed patients 52 capsular polysaccharide 52 BRAF inhibitor 52 selective estrogen receptor modulator 52 YONDELIS 52 SPL# Gel vaginal microbicide 52 Marburg virus infection 52 parasite Plasmodium falciparum 52 vivax 52 Mycobacterium bovis 52 nosocomial transmission 52 P. falciparum 52 Anticalins 52 nucleoside analogue 52 TKM Ebola 52 ZFP Therapeutic 52 Mucosal 52 FluChip 52 TLR7 agonist 52 Smac mimetics 52 Nutra Pharma wholly owned 52 virus RSV 52 proprietary BiTE ® 52 TÎ ² 4 52 lethal Ebola virus 52 short interfering RNA 52 integrase inhibitors 52 cardiometabolic disorders 52 Dendritic Cell 52 Cancer Vaccines 52 vitro assay 52 hyper virulent strain 52 GVAX ® 52 ricin toxin botulinum toxin 52 GW# [003] 52 Systemic Delivery 52 RiVax TM 52 NEUMUNE 52 anticancer compounds 52 chimeric monoclonal antibody 52 HIV Aids malaria 52 CCR1 52 Ebola Virus 52 parasite Trypanosoma cruzi 52 world safest multivalent 52 selective inhibition 52 Sanofi Pasteur ALVAC canary 52 PI3K/mTOR 52 systemic fungal infections 52 lipopeptide 52 Preclinical studies suggest 52 IMiDs ® 52 S. pneumoniae 52 hepatitis B HBV 52 SCYNEXIS 52 Nonalcoholic fatty liver 52 QUADRAMET R 52 H#N# VLP vaccine 52 African Trypanosomiasis 52 sleeping sickness Chagas 52 BRSV 52 Th2 cytokines 52 chemokine receptors 52 isotypes 52 BCR ABL inhibitors 52 OncoVEX 52 transfection reagent 52 telomerase activators 52 NanoViricides 52 fusion enhancers 52 staphylococcal infections 52 HCV protease inhibitor 52 direct thrombin inhibitors 52 biothreat agents 52 bioengineered vaccines 52 cytostatic 52 HepDirect prodrug 52 AKT inhibitor 52 Chimigen TM 52 Shigatoxin producing E. coli 52 ImmunoGen TAP technology 52 ketolide antibiotic 52 tuberculosis strep throat 52 Salmonella enterica 52 commercialize deforolimus 52 sarcoma melanoma 52 DNA methyltransferases 52 DGAT 52 VEGF inhibitors 52 immunotherapeutic 52 CD8 responses 52 CD# expressing 52 pathogenic viruses 51 IMA# 51 immunomodulating 51 live attenuated vaccines 51 protein tyrosine phosphatase 1B 51 Vaginal gel 51 c MET 51 Trypanosoma brucei 51 Virosome Biologicals 51 protein kinase inhibitors 51 synthetic retinoid 51 urogenital infections 51 NTDDS 51 Prodarsan R 51 Staphylococcus aureus infections 51 Ehrlichia 51 polyclonal antibodies 51 Factor VIIa 51 vaginal candidiasis 51 Aptamer 51 ebola marburg 51 proliferative disorders 51 DEB# 51 Multidrug resistant 51 biowarfare pathogens 51 GRNVAC1 51 TIGER biosensor system 51 p# inhibitor 51 PEGylation technology 51 Vaxfectin TM formulated 51 Opportunistic infections 51 Y. pestis 51 sorafenib tablets 51 receptor tyrosine kinase inhibitor 51 mediate antibody 51 M. genitalium 51 ENMD # 51 Bavituximab 51 class mGluR5 inhibitor 51 lipoglycopeptide 51 P. vivax 51 Yersinia pestis 51 RECOTHROM ® 51 intracellular pathogens 51 Hepatitis C Viral 51 purinergic receptors P#X# 51 targeting PCSK9 51 OMP #M# 51 Influenza Virus 51 New Chemical Entities 51 PSMA ADC 51 diphtheria whooping cough tetanus 51 Leishmania donovani 51 neuro inflammatory 51 Piperacillin 51 Ebola outbreaks 51 virology Progenics 51 epigenetic therapies 51 superantigen 51 Guanilib 51 humanized antibody 51 CCR9 antagonist 51 ddRNAi 51 Aviptadil 51 systemic RNAi therapeutic 51 proprietary BiTE R 51 alpha glucans 51 Aurora kinase inhibitor 51 Enkephalin 51 ZFN modified 51 reverse transcriptase inhibitor 51 Malaria typhoid 51 Exelixis XL# 51 RiVax ™ 51 MRSA Clostridium difficile 51 aptamer therapeutics 51 including arenaviruses Lassa 51 ribonucleotide reductase clinically validated 51 Litx 51 inflammatory demyelinating 51 adenovirus serotype 5 51 nosocomial hospital 51 molecularly targeted therapies 51 Valortim R 51 poxviruses 51 novel immunotherapies 51 alpha interferon 51 Carfilzomib 51 histone deacetylase HDAC inhibitors 51 bioterrorist weapon 51 sulfonylhydrazine class 51 Ep CAM 51 cytotoxics 51 FLT3 51 transthyretin TTR mediated amyloidosis 51 Daclizumab 51 VivaGel TM 51 Locked Nucleic Acid 51 CB1 antagonists 51 oral ghrelin agonist 51 cellular immunotherapy 51 chemotherapy induced neutropenia 51 multidrug resistant 51 aptamers 51 humanized monoclonal antibody 51 reformulates existing FDA 51 immunoregulation 51 histone deacetylase inhibitors 51 antiangiogenesis therapies 51 coronaviruses 51 endothelin receptor antagonists 51 LEAPS TM 51 Enzastaurin 51 DOS# 51 Maraviroc 51 Nexavar ® 51 MEK inhibitor 51 Small Molecule 51 therapeutic peptide 51 nucleoside reverse transcriptase inhibitor 51 M2 subunit 51 Dengue virus 51 viral diseases 51 SERMs 51 fusion proteins 51 Ibis T# 51 Smallpox vaccines 51 investigational therapies 51 immuno modulatory 51 HIV protease 51 XmAb# 51 THR beta agonist 51 chemically modified siRNA 51 Leptospira 51 adeno associated viruses 51 helminths 51 CRTH2 51 bacterium Neisseria meningitidis 51 biased ligand 51 candidiasis 51 neovascular diseases 51 echinocandin 51 mRNA antagonist 51 biodegradable nanoparticles 51 tubulin binding 51 pandemic influenza strains 51 nanomolar 51 enzyme inhibitor 51 recombinant adeno associated 51 Ebola Hemorrhagic Fever 51 FluCide ™ 51 Personalized Immunotherapy 51 lentiviral vector 51 smallpox anthrax botulism 51 CCR5 receptor antagonist 51 bacterial strains 51 XmAb ™ 51 potent recombinant 51 triterpenoids 51 agents anthrax ricin 51 oncologic diseases 51 XL# anticancer compounds 51 cyclin dependent kinase inhibitor 51 siRNA binds 51 preclinical efficacy 51 Immunotherapeutics 51 infectious diseases autoimmune 51 mertansine 51 integrase inhibitor 51 HCV RNA polymerase 51 selective kinase inhibitor 51 OMP #R# 51 neuroprotective properties 51 volociximab 51 lentiviral vectors 51 ADP receptor antagonist 51 nucleoside analog 51 cytomegalovirus 51 anticancer agents 51 MAbs 51 recombinant influenza 51 artemisinin derivative 51 histone deacetylase inhibitor 51 intranasal vaccines 51 REP# 51 cardiovascular disease autoimmune disorders 51 CXCR4 receptor 51 resistant organisms 51 anti CD# antibody 51 M. leprae 51 therapeutic antibodies 51 mediated autoimmune diseases 51 soluble tumor necrosis 51 pathogenic microorganisms 51 transmit dengue 51 humanised monoclonal antibody 51 LentiVector technology 51 parasite transmitted 51 hypervirulent 51 simian immunodeficiency virus 51 Plasmodium parasites 51 Nitazoxanide 51 Universal Flu Vaccine 51 Herpes Simplex 51 plasmid DNA vaccine 51 phosphate S1P 51 mycobacterium tuberculosis 51 Cytotoxic 51 mTOR kinase 51 thetreatment 51 vectored vaccine 51 SCIB1 51 chickenpox varicella 51 protein misfolding diseases 51 Aptamers 51 nonviral 51 Umbilical cord stem cells 51 alphavirus 51 Multimeric 51 inflammatory autoimmune 51 chimeric protein 51 herpes zoster shingles 51 faropenem 51 Therapies SRT 51 chemopreventive agents 51 botulinum neurotoxin 51 neuronal nicotinic receptor NNR 51 developing TB4 51 Candida infection 51 Staphylococcus epidermidis 51 Zoonotic 51 Ebola SNALP 51 DepoVax TM 51 mosquito Aedes aegypti 51 endogenous ligands 51 VEGF receptors 51 UsiRNAs 51 psoriasis inflammatory bowel 51 Staphylococcus Aureus 51 catalytic antioxidant compounds 51 mGluR4 51 immunodeficiency disorders 51 exon skipping 51 therapies ACTs 51 relapsed leukemia 51 sickle cell cystic fibrosis 51 Genasense evaluating 51 monoclonal antibody therapies 51 liposomal delivery 51 PKC# 51 ALN TTR# 51 anthrax botulism 51 Lymphatic filariasis 51 enzymes reverse transcriptase 51 Dr. Pasinetti 51 Enteroviruses 51 CTAP# Capsules 51 tick borne infections 51 lymphocytic choriomeningitis 51 TransVax ™ 51 H5 strains 51 protein tyrosine phosphatases 51 TTR gene 51 anthrax ricin 51 Chagas Disease 50 demonstrated anti amnesic 50 M. anisopliae 50 oncolytic virus therapies 50 Pan troglodytes 50 HER1 50 parasite Plasmodium 50 xenograft models 50 eIF 4E 50 Herpes simplex virus 50 immunological diseases 50 Ebola fever 50 Dyax phage display 50 plasmid DNA pDNA 50 thalidomide Thalomid 50 renin inhibitors 50 therapeutics diagnostics 50 Panzem NCD 50 next generation URAT1 50 Anticalins R 50 Ibis T# Biosensor System 50 M# rationally 50 P. falciparum parasites 50 peptidic compound 50 quinolone resistant 50 oral nucleoside analogue 50 Bafetinib 50 specific chemokine receptors 50 TBC M4 50 GSK# [002] 50 zoonotic pathogens 50 familial amyloidotic polyneuropathy FAP 50 RNA viruses 50 CYT# novel 50 treating neuropathic pain 50 Pneumococcus 50 Sina Bavari 50 D 1mT 50 neurokinin 1 50 #beta HSD 1 50 Systemic lupus erythematosus SLE 50 myeloproliferative disorders 50 Alinia 50 Chemokine 50 activate SIRT1 50 commercialize OncoGenex lead 50 NNRTIs 50 Extensively Drug Resistant Tuberculosis 50 investigational integrase inhibitor 50 antisense inhibitor 50 androgen receptor AR 50 neurology immunology 50 ADCC enhanced 50 ZFNs 50 JAK#/JAK# 50 GeoVax vaccine 50 polio diphtheria 50 receptor PPAR 50 antibiotic methicillin 50 CD4 monoclonal antibody 50 soil transmitted helminths 50 Angiolix 50 HIV AIDS neuropathic pain 50 NIH NIAID 50 Archexin 50 DGAT1 inhibitors 50 virulence factors 50 emtricitabine FTC